Do you want to know more about Parkinson's? PDF's materials provide information about symptoms, medications, resources & more.
New York State to Fund Stem Cell
- Apr 02 2007
New York State has finally entered the stem cell arena with the intention of becoming a big-time player second only to California. The state will put $100 million into the research in fiscal year 2008, and stem cell supporters expect the number ultimately to reach $1 billion over a decade. On the night of 31 March, minutes before the beginning of the state's 2008 fiscal year, legislators passed a budget that includes $100 million for stem cell research. The money will be administered by a new entity set up within the state health department. In addition, for the next 10 years, the state will provide up to $50 million annually for stem cell research from a fund created from the sale of state-run insurance plans to private entities. In addition to this, according to Robin Elliott, head of the Parkinson's Disease Foundation in New York, and member of the coalition New Yorkers for the Advancement of Medical Research, stem cell supporters are optimistic that the legislature will appropriate an additional $50 million a year.
State legislators have been trying for years to set up a stem cell initiative. They were able to pull it off this year thanks to the support of a new Democratic governor, Eliot Spitzer. Elected last year, Spitzer initially wanted a California-style bond issue to raise $1 billion for stem cell research in New York.
The newly passed measure outlaws reproductive cloning but makes no mention of research cloning--otherwise known as somatic cell nuclear transfer. Elliott says the measure is couched in the vaguest possible terms in order to avoid kicking up resistance from opponents of human embryonic stem cell research. The words "human" and "embryonic" do not appear in the text, which also does not mention federal policies that prohibit federally funded researchers from doing research with human embryonic cell lines created since 2001.
Researchers are "deeply grateful" that New York has taken the stem cell plunge, says Kenneth Davis, president of New York's Mount Sinai Medical Center. The law calls for the establishment of a 13-member Empire State Stem Cell Board to be appointed by the governor, which will administer the new Empire State Stem Cell Fund for research in the state. It's good to have it "right in the heart of the bureaucracy," says Elliott--in part because it will not be vulnerable to lawsuits as in the case of the California Institute for Regenerative Medicine. Elliott says the board will set up panels of outside scientists--most likely not from New York--to review the grants.
Source: ScienceNOW Daily News
New York State Budget Passes with $100 Million for Stem Cell and Regenerative Medicine Research
Commentary from the Parkinson's Disease Foundation
On Saturday, March 31, Governor Eliot Spitzer, Lieutenant-Governor David Paterson, Senate Majority Leader Joseph Bruno and Assembly Speaker Sheldon Silver signed off on a long-term package to fund stem-cell and regenerative medicine research in the State of New York, beginning with an appropriation of $100 million for Fiscal Year 2008 that begins April 1, 2007. Leading the charge on this initiative was New Yorkers for the Advancement of Medical Research (NYAMR), the statewide coalition of some 46 universities, health advocacy groups and citizens' organizations that was set up four years ago to campaign for State support of stem-cell and regenerative medicine research. Robin Anthony Elliott, Executive Director of the Parkinson's Disease Foundation and Chair of NYAMR, applauded the move in his statement below.
"This is a terrific piece of legislation. Albany's decision to appropriate $100 million for stem-cell and regenerative medicine research in FY2008, along with the prospect of additional funding at the same level for a decade, will clearly define the State of New York as a world leader in this crucial and very promising area of research. It will send a signal that our State means business in this important area of science; will help us to retain the gifted scientists that we already have, and to attract others from elsewhere; will invigorate economic development in several areas of the State; and will offer New Yorkers new hope for future cures of chronic and degenerative conditions such as spinal cord injury, Type-One diabetes, and Parkinson's disease.
"For this decisive and courageous action, all of our state leaders -- Lieutenant-Governor Paterson, Governor Spitzer, Assembly Speaker Silver, Senate Majority Leader Bruno and all who supported them in both houses of the Legislature -- deserve the thanks and applause of everyone in our State who cares about the importance of making a long-term investment in the solution of human disease."
Source Date: Apr 02 2007
Source Publication: ScienceNOW Daily News